According to a recent LinkedIn post from MintNeuro, CEO and co‑founder Dorian Haci, PhD, is presenting the company at the Start-Up Showcase during WIRED Health London 2026. The session, scheduled for the morning of April 16 at Outernet London, is positioned as an introduction to MintNeuro’s advanced semiconductor solutions for next‑generation neurotechnology.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that the presentation will focus on minimally invasive neural implants and their potential to transform brain health. Framing MintNeuro’s technology in this context may indicate the company’s ambition to target high‑growth segments such as brain‑computer interfaces and neural interfaces, where semiconductor innovation is a key differentiator.
By highlighting participation in WIRED Health, which the post describes as a gathering of disruptors, scientists, medical pioneers, and industry leaders, MintNeuro appears to be seeking visibility among strategic partners and investors. Exposure at a curated health innovation event could support future funding, collaboration opportunities, and validation of its technology roadmap.
The emphasis on on-site team presence and a call for attendees to connect underscores a business development focus rather than a concrete commercial announcement. For investors, the post may signal that MintNeuro is still in a growth and ecosystem-building phase, with value creation likely tied to successful technology demonstration, regulatory progress, and eventual adoption in clinical or research settings.